Physician

Nader Moinfar, MD

According to 2025 Medicare claims, Nader Moinfar, MD (NPI: 1740206028) practices ophthalmology in the Lakeland-Winter Haven, FL market, with the plurality of this provider's patient population coming from Polk, FL. This provider's primary affiliated billing organization is FLORIDA RETINA CONSULTANTS P.A. (NPI: 1053392209; TIN: 200092126) and primary practice location at 33880-4126.

Moinfar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 570 traditional Medicare patients, billed 68,774 HCPCS/CPT codes, and received $1,748,817 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 975 prescription claims across 257 beneficiaries totaling $92,363 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 3 records totaling $151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $702,654 to $1,748,817. Similarly, Part D prescription costs have risen steadily, from $10,699 to $92,363. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$874K$1.7M2015 Medicare payment: $702,654 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $260,110 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $377,304 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $951,784 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,391,919 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,479,853 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $970,081 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,037,748 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,403,999 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,748,817 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153994,323$702,654
20163663,876$260,110
20173733,614$377,304
20187125,440$951,784
20197206,752$1,391,919
20206295,519$1,479,853
20213734,965$970,081
202249610,165$1,037,748
202360736,373$1,403,999
202457068,774$1,748,817

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$92K2015 Drug cost: $10,699 (USD; Tot_Drug_Cst)2016 Drug cost: $14,297 (USD; Tot_Drug_Cst)2017 Drug cost: $10,833 (USD; Tot_Drug_Cst)2018 Drug cost: $27,370 (USD; Tot_Drug_Cst)2019 Drug cost: $44,624 (USD; Tot_Drug_Cst)2020 Drug cost: $37,519 (USD; Tot_Drug_Cst)2021 Drug cost: $65,182 (USD; Tot_Drug_Cst)2022 Drug cost: $41,166 (USD; Tot_Drug_Cst)2023 Drug cost: $85,637 (USD; Tot_Drug_Cst)2024 Drug cost: $92,363 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201566181$10,699
201666163$14,297
201772176$10,833
2018107275$27,370
2019112312$44,624
2020125377$37,519
2021118327$65,182
2022117323$41,166
2023244852$85,637
2024257975$92,363

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system197344$92
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more259426$89
67028Injection of drug into eye178896$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more164224$72
92134Imaging of retina5051,291$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol321,736$13,224
LumiganBimatoprost201,254$11,000
RestasisCyclosporine13450$7,991
RhopressaNetarsudil Mesylate16462$6,082
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol281,716$5,131

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$151Ocular Therapeutix, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nader Moinfar, MD?

Tedicare shows public-source Medicare data for Nader Moinfar, MD (NPI 1740206028), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nader Moinfar, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nader Moinfar, MD?

Nader Moinfar, MD is linked to FLORIDA RETINA CONSULTANTS P.A. (billing NPI 1053392209) in the available physician profile data.

Does Nader Moinfar, MD have Open Payments data?

Nader Moinfar, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.